Polycystic ovary syndrome and metformin in pregnancy

Acta Obstetricia et Gynecologica Scandinavica

Volumn 85, Issue 7, 2006, Pages 861-868

  Lilja, Anna ^a   Mathiesen, Elisabeth ^a  

^a Rigshospitalet   (Denmark)

Author keywords

Metformin therapy; Polycystic ovary syndrome; Pregnancy

Indexed keywords

CLOMIFENE; INSULIN; METFORMIN; PLACEBO; SULFONYLUREA;

ABORTION; ACHONDROPLASIA; ANOVULATION; ARTICLE; CLINICAL TRIAL; CONCEPTION; CORRELATION ANALYSIS; DRUG EFFECT; DRUG EFFICACY; DRUG FATALITY; DRUG INDICATION; DRUG MECHANISM; DRUG POTENTIATION; DRUG SAFETY; FEMALE INFERTILITY; FETUS DEATH; FETUS DISEASE; GASTROINTESTINAL SYMPTOM; GLUCOSE BLOOD LEVEL; HEALTH CARE COST; HORMONAL REGULATION; HUMAN; HYPERANDROGENISM; HYPERINSULINEMIA; HYPOGLYCEMIA; INSULIN SENSITIVITY; LACTIC ACIDOSIS; LAPAROSCOPIC OVARIAN DRILLING; LAPAROSCOPIC SURGERY; LIPID BLOOD LEVEL; MATERNAL HYPERTENSION; MENSTRUAL CYCLE; MENSTRUAL IRREGULARITY; MULTIPLE PREGNANCY; NEWBORN DISEASE; NONHUMAN; NUTRITIONAL DEFICIENCY; OVARY FUNCTION; OVARY HYPERSTIMULATION; OVARY POLYCYSTIC DISEASE; OVULATION; PERINATAL MORTALITY; PREECLAMPSIA; PREGNANCY COMPLICATION; PREGNANCY DIABETES MELLITUS; PRIORITY JOURNAL; TERATOGENICITY; VITAMIN DEFICIENCY;

DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; METFORMIN; OVULATION INDUCTION; POLYCYSTIC OVARY SYNDROME; PREGNANCY; PREGNANCY COMPLICATIONS;

EID: 33745610746     PISSN: 00016349     EISSN: 16000412     Source Type: Journal    
DOI: 10.1080/00016340600780441     Document Type: Article

References (47)

1. The Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 2004;81:19-25.
2. The Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 2004;19:41-7.
3. Hopkinson Z, Sattar N, Fleming R, Greer I. Polycystic ovarian syndrome: the metabolic syndrome comes to gynecology. BMJ. 1998;317:329-32.
4. Fridström M. Endocrine and therapeutic aspects of infertile women with the polycystic ovary syndrome. Department of Clinical Science, Division of Obstetrics and Gynaecology, Karolinska Institute, Huddinge University Hospital, Stockholm, Sweden, 1998.
5. Guzick DS. Polycystic ovary syndrome. Obstet Gynecol. 2004;103:181-93.
6. Dunaif A. Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocr Rev. 1997;18:774-800.
7. Driscoll DA. Polycystic ovary syndrome in Adolescence. Ann N Y Acad Sci. 2003;997:49-55.
8. Hassan M, Killick S. Ultrasound diagnosis of polycystic ovaries in women who have no symptoms of polycystic ovary syndrome is not associated with subfecundity or subfertility. Fertil Steril. 2003;80:966-75.
9. Boss A. Living with PCOS. Addicus Books; 2001.
10. Ovesen P, Møller N, Griesen S, Ingerslev HJ. Polycystisk ovarie-syndrom I [Polycystic ovary syndrome I] (in Danish). Ugeskrift for læger 12. januar 1998;260-4.
11. Ovesen P, Møller N, Griesen S, Ingerslev HJ. Polycystisk ovarie-syndrom II [Polycystic ovary syndrome II] (in Danish). Ugeskrift for læger 12. januar 1998;265-9.
12. Franks S. Polycystic ovary syndrome. N Engl J Med. 1995; 333:853-61.
13. McFarlane KJ, Isé C, Linton C. Polycystic ovarian syndrome and insulin resistance. Endocrinology. 2002;4:623-6.
14. McCarthy EA, Walker SP, McLachlan K, Boyle J, Permezel M. Metformin in obstetric and gynecologic practice: a review. Obstet Gynecol Surv. 2004;59:118-26.
15. Harbone L, Fleming R, Lyall H, Sattar N. Descriptive review of the evidence for the use of metformin in polycystic ovary syndrome. Lancet. 2003;361:1894-901.
16. Lord JM, Flight IH, Norman RJ. Metformin in polycystic ovary syndrome: systematic review and meta-analysis. BMJ. 2003;327:951-6.
17. Muth S, Normann J, Sattar N, Fleming R. Women with polycystic ovary syndrome (PCOS) often undergo protracted treatment with metformin and are disinclined to stop: indications for a change in licensing arrangements? Hum Reprod. 2004;19:2718-20.
18. Pedersen C, Bjerrum L, Friis H, Hendel J. Lægemiddelkataloget. Dansk Lægemiddel-information A/S. 2006. (www.lmk.dk).
19. Bruni V, Dei M, Pontello V, Vangelisti P. The management of polycystic ovary syndrome. Ann N Y Acad Sci. 2003;997: 307-21.
20. Morin-Papunen L, Vauhkonen I, Koivunen R, Ruokonen A, Martikainen H, Tapanainen J. Endocrine and metabolic effects of metformin versus ethinyl estradiol-cyproterone acetate in obese women with polycystic ovary syndrome: a randomized study. J Clin Endocrinol Metab. 2000;85:3161-8.
21. Laven J, Mulders A, Visser J, Themmen A, De Jong F, Fauser B. Anti-Müllerian hormone serum concentrations in normoovulatory and anovulatory women of reproductive age. J Clin Endocrinol Metab. 2004;89:318-23.
22. Piltonen T, Morin-Papunen L, Koivunen R, Perheentupa A, Roukonen A, Tapanainen J. Serum anti-Müllerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome. Hum Reprod. 2005;20:1820-6.
23. Kocak M, Caliskan E, Simsir C, Haberal A. Metformin therapy improves ovulatory rates, cervical scores, and pregnancy rates in clomifen citrate-resistant women with polycystic ovary syndrome. Fertil Steril. 2003;77:101-6.
24. Heard MJ, Pierce A, Carson SA, Buster JE. Pregnancies following use of metformin for ovulation induction in patients with polycystic ovary syndrome. Fertil Steril. 2002;77:669-73.
25. Pirwany I, Tulandi T. Laparoscopic treatment of polycystic ovaries: is it time to relinquish the procedure? Fertil Steril. 2003;80:241-51.
26. Palomba S, Orio F, Nardo L, Falbo A, Russo T, Corea D, et al. Metformin administration versus laparoscopic ovarian diathermy in clomiphene citrate-resistant women with polycystic ovary syndrome: a prospective parallel randomized double-blind placebo-controlled trial. J Clin Endocrinol Metab. 2004;89:4801-9.
27. De Leo V, la Marca A, Ditto A, Morgante G, Cianci A. Effects of metformin on gonadotropin-induced ovulation in women with polycystic ovary syndrome. Fertil Steril. 1999; 72:282-5.
28. Palomba S, Falbo A, Orio F, Manguso F, Russo T, Tolino A, et al. A randomized controlled trial evaluating metformin pretreatment and co-administration in non-obese insulin-resistant women with polycystic ovary syndrome treated with controlled ovarian stimulation plus timed intercourse or intrauterine insemination. Hum Reprod. 2005;20:2879-86.
29. Yarari H, Yildiz B, Demirol A, Zeyneloglu H, Yigit N, Bükülumez O, et al. Co-administration of metformin during rFSH treatment in patients with clomiphene citrate-resistant polycystic ovarian syndrome: a prospective randomized trial. Hum Reprod. 2002;17:289-94.
30. Farquhar C, Vandekerckhove P, Lilford R. Laparoscopic "drilling" by diathermy or laser for ovulation induction in anovulatory polycystic ovary syndrome. Cochrane Database Syst Rev 2005, issue 2.
31. Vandermolen DT, Ratts VS, Evans WS, Stovall DW, Kauma SW, Nestler JE. Metformin increases the ovulatory rate and pregnancy rate from clomiphene citrate in patients with polycystic ovary syndrome who are resistant to clomiphene citrate alone. Fertil Steril. 2001;75:310-5.
32. Kjøtrod S, von Düring V, Carlsen S. Metformin treatment before IVF/ICSI in women with polycystic ovary syndrome; a prospective, randomized, double blind study. Hum Reprod. 2004;19:1315-22.
33. Palomba S, Orio F, Falbo A, Manguso F, Russo T, Cascella T, et al. Prospective parallel randomized, double-blind, double-dummy controlled clinical trial comparing clomiphene citrate and metformin as the first-line treatment for ovulation induction in nonobese anovulatory women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2005; 90:4068-74.
34. Mikola M, Hiilesmaa V, Halttunen M, Suhonen L, Tiitinen A. Obstetric outcome in women with polycystic ovarian syndrome. Hum Reprod. 2001;16:226-9.
35. Jakubowics DJ, Iuorno MJ, Jakubowicz S, Roberts KA, Nestler JE. Effects of metformin on early pregnancy loss in the polycystic ovary syndrome. J Clin Endocrinol Metab. 2002;87:524-9.
36. Glueck CJ, Phillips H, Cameron D, Wang P, Sieve-Smith L. Continuing metformin throughout pregnancy in women with polycystic ovary syndrome appears to safely reduce first-trimester spontaneous abortion: a pilot study. Fertil Steril. 2001;75:46-52.
37. Glueck CJ, Wang P, Goldenberg N, Sieve-Smith L. Pregnancy outcomes among women with polycystic ovary syndrome treated with metformin. Hum Reprod. 2002;17:2858-64.
38. Glueck CJ, Phillips H, Wang P, Sieve-Smith L, Kobayashi S. Metformin therapy throughout pregnancy reduces the development of gestational diabetes in women with polycystic ovary syndrome. Fertil Steril. 2002;77:520-5.
39. Glueck C, Bornovali S, Pranikoff J, Goldenberg N, Dharashivkar S, Wang P. Metformin, pre-eclampsia, and pregnancy outcomes in women with polycystic ovaries syndrome. Diabet Med. 2004;21:829-36.
40. Glueck CJ, Wang P, Fontaine R, Tracy T, Sieve-Smith L. Metformin-induced resumption of normal menses in 39 of 43 (91%) previously amenorrheic women with the polycystic ovary syndrome. Metabolism. 1999;48:511-9.
41. Jakubowics DJ, Seppälä M, Jakubowicz S, Rodriguez-Armas O, Rivas-Santiago A, Koistinen H, et al. Insulin reduction with metformin increases luteal phase serum glycodelin and insulin-like growth factor-binding protein-1 concentrations and enhances uterine vascularity and blood flow in the polycystic ovary syndrome. J Clin Endocrinol Metab. 2001; 86:1126-33.
42. Jakubowics DJ, Essah PA, Seppälä M, Jakubowicz S, Baillargeon J-P, Koistinen H, et al. Reduced serum glycodelin and insulin-like growth factor-binding protein-1 in women with polycystic ovary syndrome during first trimester of pregnancy. J Clin Endocrinol Metab. 2004;89:833-9.
43. Stadtmauer LA, Toma SK, Riehl RM, Talbert LM. Metformin treatment of patients with polycystic ovary syndrome undergoing in vitro fertilization improves outcomes and is associated with modulation of the insulin-like growth factors. Fertil Steril. 2001;75:505-9.
44. Vanky E, Salvesen K, Heimstad R, Fougner K, Romundstad P, Carlsen S. Metformin reduces pregnancy complications without affecting androgen levels in pregnant polycystic ovary syndrome women: results of a randomized study. Hum Reprod. 2004;19:1734-40.
45. Koivunen R, Juutinen J, Vauhkonen I, Morin-Papunen L, Ruokonen A, Tapanainen J. Metabolic and steriodogenic alternations related to increased frequency of polycystic ovaries in women with a history of gestational diabetes. J Clin Endocrinol Metab. 2001;86:2591-9.
46. Hellmuth E, Damm P, Molsted-Pedersen L. Oral hypoglycemic agents in 118 diabetic pregnancies. Diabet Med. 2000; 17:507-11.
47. Glueck C, Goldenberg N, Pranikoff J, Loftspring M, Sieve L, Wang P. Height, weight, and motor-social development during the first 18 months of life in 126 infants born to 109 mothers with polycystic ovary syndrome who conceived on and continued metformin through pregnancy. Hum Reprod. 2004;19:1323-30.